SNPs of Excision Repair Cross Complementing Group 5 and Gastric Cancer Risk in Chinese Populations |
Yang, Wan-Guang
(Department of Emergency, the First Affiliated Hospital)
Zhang, Shan-Feng (School of Basic Medicine, Zhengzhou University) Chen, Ju-Wu (Department of Emergency, the First Affiliated Hospital) Li, Li (Department of Emergency, the First Affiliated Hospital) Wang, Wan-Peng (Department of Emergency, the First Affiliated Hospital) Zhang, Xie-Fu (Department of Gastrointestinal Surgery, the First Affiliated Hospital) |
1 | Hussain SK, Mu LN, Cai L, et al (2009). Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. Cancer Epidemiol Biomarkers Prev, 18, 2304-9. DOI ScienceOn |
2 | International Agency for Research on Cancer (1994). Schistostomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of cancer risks to humans, vol 61. International Agency for Research on Cancer, Lyon. |
3 | International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC. |
4 | Kiyohara C, Yoshimasu K (2007). Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a metaanalysis. Int J Med Sci, 4, 59-71. |
5 | Klungland A, Hoss M, Gunz D, et al (1999). Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell, 3, 33-42. DOI ScienceOn |
6 | Zhu ML, Shi TY, Hu HC, et al (2012). Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations. PLoS One, 7, e41500. DOI |
7 | Zhu ML, Wang M, Cao ZG, et al (2012). Association between the ERCC5 Asp1104His polymorphism and cancer risk: a metaanalysis. PLoS One, 7, e36293. DOI |
8 | Chang JS, Wrensch MR, Hansen HM, et al (2008). Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer, 123, 2095-104. DOI ScienceOn |
9 | Correa P (1992). Human Gastric carcinogenesis: a multistep and multifactorial process: first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40. |
10 | Correa P (1997). Helicobacter pylori as a pathogen and carcinogen. J Physiol Pharmacol, 48, 19-24. |
11 | Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. DOI ScienceOn |
12 | Dixon MF, Genta RM, Yardley JH, et al (1996). Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol, 20, 1161-81. |
13 | Duan Z, He C, Gong Y, et al (2012). Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene, 511, 274-9. DOI ScienceOn |
14 | Farinati F, Cardin R, Cassaro M, et al (2008). Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev, 17, 195-200. DOI ScienceOn |
15 | Friedberg EC, Bond JP, Burns DK, et al (2000). Defective nucleotide excision repair in XPC mutant mice and its association with cancer predisposition. Mutat Res, 459, 99-108. DOI ScienceOn |
16 | Mueser TC, Nossal NG, Hyde CC (1996). Structure of bacteriophage T4 RNase H, a 50 to 30 RNA-DNA and DNA-DNA exonuclease with sequence similarity to the RAD2 family of eukaryotic proteins. Cell, 85, 1101-12. DOI ScienceOn |
17 | Liu D, Wu HZ, Zhang YN, et al (2012). DNA repair genes XPC, XPG polymorphisms: Relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin-based adjuvant chemotherapy. Mol Carcinog, 1, E83-93. |
18 | Lu HT, Ouyang WM, Huang CS (2006). Inflammation, a key event in cancer development. Mol Cancer Res, 4, 221-33. DOI ScienceOn |
19 | Ma H, Yu H, Liu Z, et al (2012). Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics, 22, 50-7. DOI ScienceOn |
20 | Pan J, Lin J, Izzo JG, et al (2009). Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis, 30, 785-92 DOI ScienceOn |
21 | Parsonnet J, Friedman GD, Orentreich N, et al (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40, 297-301. DOI |
22 | Price AB (1991). The Sydney system: histological division. J Gastroenterol Hepatol, 6, 209-22. DOI ScienceOn |
23 | Rouissi K, Bahria IB, Bougatef K, et al (2011). The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer, 11, 101. DOI |
24 | Singh K, Ghoshal UC (2006). Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol, 12, 1346-51. |
25 | Sipponen P, Marshall BJ (2000). Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am, 29, 579-92. DOI ScienceOn |
26 | He J, Qiu LX, Wang MY, et al (2012). Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet, 131, 1235-44. DOI ScienceOn |
27 | Ghoshal UC, Tiwari S, Dhingra S, et al (2008). Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasm and controls: the Indian enigma. Dig Dis Sci, 53, 1215-22. DOI ScienceOn |
28 | Ghoshal UC, Tripathi S, Ghoshal U (2007). The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host's genetic make up, or friendly bug? Am J Gastroenterol, 102, 2113-4. DOI ScienceOn |
29 | Graham DY, Adam E, Reddy GT, et al (1991). Seroepidemiology of Helicobacter pylori infection in India; comparison of developing and developing countries. Dig Dis Sci, 36, 1084-8. DOI ScienceOn |